Acular (ketorolac tromethamine ophthalmic solution) 0.5%

Company
Allergan

Approval Status
Approved January 1997

Treatment for
Treatment for postoperative inflammation in patients who have undergone cataract extraction

Possible similar drugs
Acular

Areas
Eye Health / Ophthalmology

Acular has been approved for the treatment of postoperative inflammation in patients who have undergone cataract extraction.

Acular (ketorolac tromethamine ophthalmic solution) 0.5% Drug Information

The Acular (ketorolac tromethamine ophthalmic solution) 0.5% drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top